Table 2.

Guideline Concordance and Timing of Diagnostic Mammogram/Colonoscopy Orders

	Breast lump	Rectal bleeding	p value
Concordance of testing with CRICO Decision Support Toola,b	N = 300	N = 300	p value†
Of total presenting, % (N) for whom clinical guidelines recommend mammogram for breast lump or colonoscopy for rectal bleeding	100% (300)	89% (268)	< 0.01
Of total for whom mammogram/colonoscopy is recommended, % (N) for whom an order was placed	88% (264)	73% (196)	< 0.01
Among patients for whom order is placed, timing of order placement relative to presentation*	N = 264	N = 196
At initial presentation	97% (257)	86% (169)	< 0.01
Within 30 days of presentation	1% (3)	5% (10)
Between 31 and 60 days after presentation	1% (2)	1% (2)
Between 61 and 365 days after presentation	1% (2)	8% (15)
Among patients for whom order is placed, timing of order completion*	N = 264	N = 196
Within 30 days of order placement	84% (221)	31% (61)
Between 31 and 90 days after order placement	6% (17)	26% (51)	< 0.01
Between 91 and 365 days after order placement	3% (8)	16% (32)
Not completed within 365 days	7% (18)	27% (52)

*Orders correspond to mammograms for chief complaints of breast lump and to colonoscopies for chief complaints of rectal bleeding

†Using chi-squared test

^aControlled Risk Insurance Company. CRICO Breast Care Management Algorithm: A Decision Support Tool.; 2014.

^bControlled Risk Insurance Company. Prevention & Early Detection of Colorectal Cancer: A CRICO Decision Support Tool.; 2014.